NO942378L - Anvendelse av arylindolderivater for behandling av psykoser - Google Patents
Anvendelse av arylindolderivater for behandling av psykoserInfo
- Publication number
- NO942378L NO942378L NO942378A NO942378A NO942378L NO 942378 L NO942378 L NO 942378L NO 942378 A NO942378 A NO 942378A NO 942378 A NO942378 A NO 942378A NO 942378 L NO942378 L NO 942378L
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen
- alkyl
- psychoses
- treatment
- cycloalkylmethyl
- Prior art date
Links
- 208000028017 Psychotic disease Diseases 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 229910052799 carbon Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004981 cycloalkylmethyl group Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 229910052717 sulfur Chemical group 0.000 abstract 2
- 239000011593 sulfur Chemical group 0.000 abstract 2
- 125000002030 1,2-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([*:2])C([H])=C1[H] 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 239000011737 fluorine Chemical group 0.000 abstract 1
- 229910052731 fluorine Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- HDCXQTPVTAIPNZ-UHFFFAOYSA-N n-({[4-(aminosulfonyl)phenyl]amino}carbonyl)-4-methylbenzenesulfonamide Chemical group C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NC1=CC=C(S(N)(=O)=O)C=C1 HDCXQTPVTAIPNZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- 210000004515 ventral tegmental area Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK912065A DK206591D0 (da) | 1991-12-23 | 1991-12-23 | Behandling af psykoser |
| PCT/DK1992/000390 WO1993012790A1 (en) | 1991-12-23 | 1992-12-21 | Use of arylindole derivatives for the treatment of psychoses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO942378L true NO942378L (no) | 1994-06-22 |
| NO942378D0 NO942378D0 (en:Method) | 1994-06-22 |
Family
ID=8109829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942378A NO942378L (no) | 1991-12-23 | 1994-06-22 | Anvendelse av arylindolderivater for behandling av psykoser |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0618799A1 (en:Method) |
| JP (1) | JPH07502517A (en:Method) |
| AU (1) | AU668537B2 (en:Method) |
| CA (1) | CA2126571A1 (en:Method) |
| CZ (1) | CZ153994A3 (en:Method) |
| DK (1) | DK206591D0 (en:Method) |
| NO (1) | NO942378L (en:Method) |
| RU (1) | RU94031165A (en:Method) |
| SK (1) | SK75794A3 (en:Method) |
| WO (1) | WO1993012790A1 (en:Method) |
| ZA (1) | ZA9210001B (en:Method) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5554030A (en) * | 1994-06-30 | 1996-09-10 | Minnesota Mining And Manufacturing Company | Method for bonding non-amalgam restorative materials to dental surfaces |
| EP0932407A4 (en) * | 1996-03-25 | 2002-04-24 | Lilly Co Eli | TECHNIQUE FOR TREATING MIGRAINE PAIN |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
| GB8908085D0 (en) * | 1989-04-11 | 1989-05-24 | Lundbeck & Co As H | New therapeutic use |
| DK158590D0 (da) * | 1990-07-02 | 1990-07-02 | Lundbeck & Co As H | Indolderivater |
| DK238190D0 (da) * | 1990-10-03 | 1990-10-03 | Lundbeck & Co As H | Depotderivater |
| DK8492D0 (da) * | 1992-01-23 | 1992-01-23 | Lundbeck & Co As H | Behandling af psykoser |
-
1991
- 1991-12-23 DK DK912065A patent/DK206591D0/da not_active Application Discontinuation
-
1992
- 1992-12-21 RU RU94031165/14A patent/RU94031165A/ru unknown
- 1992-12-21 JP JP5511365A patent/JPH07502517A/ja active Pending
- 1992-12-21 SK SK757-94A patent/SK75794A3/sk unknown
- 1992-12-21 CA CA002126571A patent/CA2126571A1/en not_active Abandoned
- 1992-12-21 EP EP93902096A patent/EP0618799A1/en not_active Ceased
- 1992-12-21 AU AU33452/93A patent/AU668537B2/en not_active Ceased
- 1992-12-21 WO PCT/DK1992/000390 patent/WO1993012790A1/en not_active Ceased
- 1992-12-21 CZ CZ941539A patent/CZ153994A3/cs unknown
- 1992-12-23 ZA ZA9210001A patent/ZA9210001B/xx unknown
-
1994
- 1994-06-22 NO NO942378A patent/NO942378L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU94031165A (ru) | 1996-06-20 |
| AU668537B2 (en) | 1996-05-09 |
| JPH07502517A (ja) | 1995-03-16 |
| NO942378D0 (en:Method) | 1994-06-22 |
| CZ153994A3 (en) | 1995-06-14 |
| AU3345293A (en) | 1993-07-28 |
| CA2126571A1 (en) | 1993-07-08 |
| EP0618799A1 (en) | 1994-10-12 |
| DK206591D0 (da) | 1991-12-23 |
| WO1993012790A1 (en) | 1993-07-08 |
| ZA9210001B (en) | 1994-01-13 |
| SK75794A3 (en) | 1995-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69129998D1 (de) | Pyrimidindionderivate, deren Herstellung und Verwendung | |
| YU56492A (sh) | Derivati hinuklidina | |
| NO306237B1 (no) | Anvendelse av xantinderivater som antidepressive midler | |
| HUP0000739A2 (hu) | Alkánszulfonil-amino-csoportot tartalmazó alkán- és heterociklusos karbonsavszármazékok, az ezeket tartalmazó gyógyszerkészítmények, valamint csontritkulás kezelésére szolgáló kombinált gyógyszerkészítmények | |
| ATE139233T1 (de) | Annelierte thiophen-derivate, ihre herstellung und verwendung | |
| DE69329727D1 (de) | Neue imidazol derivate, ihre herstellung und therapeutische verwendung | |
| HU911001D0 (en) | 3,5-di-tertian-buthyl-4-hydroxy-phenyl-methylene derivatives of 2-substituted tiazolidinones and imidazolidinones as antiflammable active agents | |
| DE69526862D1 (de) | Azol-derivate | |
| ATE110729T1 (de) | Cephalosporinverbindungen, verfahren zu ihrer herstellung und antibakterielle mittel. | |
| DK0453042T3 (da) | Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner | |
| DE69004984D1 (de) | Di-tert-butyl-hydroxyphenylthioderivate, deren Herstellung und Verwendung. | |
| CA2016181A1 (en) | Arylthiazolylimidazoles as 5ht3 antagonists | |
| DE69109132D1 (de) | Indanderivate. | |
| ES8203354A1 (es) | Un procedimiento para la produccion de nuevos derivados heterociclicos,. | |
| ATE143597T1 (de) | Imidazol-1-yl-verbindung enthaltende arzneimittel | |
| ATE176233T1 (de) | Imidazo(1,2-c)chinazolinderivate als antihypertensive und antidysurie | |
| NO302365B1 (no) | Alkylderivater av trazodon med CNS-aktivitet | |
| SE8303913L (sv) | Heterocykliska foreningar | |
| FR2660862B1 (fr) | Application therapeutique de derives de l'histamine, nouveau derive de l'histamine et utilisation de ces derives pour la preparation de medicaments. | |
| DE69509231D1 (de) | 3-substituierte pyridinverbindungen und deren derivate als herbizide | |
| NO304350B1 (no) | Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater til behandling for avhengighet av droger og narkotika | |
| KR900701784A (ko) | 소염 활성을 갖는 헤테로비사이클릭 화합물 | |
| DE69203732D1 (de) | Substituierte Alkensäure und ihre Derivate. | |
| DE3782235D1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
| DE69407042D1 (de) | Psoralen-derivate, deren herstellung und verwendung als arzneimittel |